A detailed history of Oarsman Capital, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Oarsman Capital, Inc. holds 1,770 shares of ZTS stock, worth $305,696. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,770
Holding current value
$305,696
% of portfolio
0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$172.58 - $196.48 $305,466 - $347,769
1,770 New
1,770 $345,000
Q4 2023

Feb 16, 2024

BUY
$151.44 - $200.09 $161,737 - $213,696
1,068 New
1,068 $210,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $80.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Oarsman Capital, Inc. Portfolio

Follow Oarsman Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.